Association of maternal diseases during pregnancy with the risk of single ventricular septal defects in the offspring - A population-based case-control study

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 26, Issue 8, 2013, Pages 738-747

  Csáky Szunyogh, Melinda ^a   Vereczkey, Attila ^b   Kósa, Zsolt ^b   Urbán, Róbert ^c   Czeizel, Andrew E ^d  

^a Hungarian Congenital Abnormalities Registry   (Hungary)

^b Versys Clinics   (Hungary)

^c EÖTVÖS LORÁND UNIVERSITY   (Hungary)

^d FOUNDATION FOR THE COMMUNITY CONTROL OF HEREDITARY DISEASES   (Hungary)

Author keywords

Antifever therapy; Epilepsy; Folic acid supplementation; Influenza; Paroxysmal supraventricular tachycardia; Population based case control study; Ventricular septal defect

Indexed keywords

ACETYLSALICYLIC ACID; ALLYLESTRENOL; AMINOPHENAZONE; AMINOPHYLLINE; AMPICILLIN; ANTICONVULSIVE AGENT; BENCYCLANE; BROMHEXINE; CARBAMAZEPINE; CEFALEXIN; CLOPAMIDE; CLOTRIMAZOLE; DIAZEPAM; DIMENHYDRINATE; DIPYRONE; DROTAVERINE; ETHOSUXIMIDE; FENOTEROL; FOLIC ACID; FUROSEMIDE; HYDROXYPROGESTERONE; MEPHENYTOIN; MORSUXIMIDE; PARACETAMOL; PHENACEMIDE; PHENYTOIN; PRIMIDONE; SULTIAME; UNCLASSIFIED DRUG; UNINDEXED DRUG; VALPROIC ACID;

ACUTE DISEASE; ARTICLE; CHRONIC DISEASE; CONGENITAL HEART MALFORMATION; CONTROLLED STUDY; DRUG MEGADOSE; EPILEPSY; FEMALE; FETUS; FEVER; FIRST TRIMESTER PREGNANCY; HEART VENTRICLE SEPTUM DEFECT; HUMAN; INFLUENZA; MAJOR CLINICAL STUDY; MATERNAL DISEASE; MOTHER; NEWBORN; PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA; POPULATION BASED CASE CONTROL STUDY; PREGNANCY; PRIORITY JOURNAL; PROGENY; RISK ASSESSMENT; RISK REDUCTION;

CASE-CONTROL STUDIES; FEMALE; FOLIC ACID; HEART SEPTAL DEFECTS, VENTRICULAR; HUMANS; HUNGARY; POPULATION SURVEILLANCE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; TACHYCARDIA, PAROXYSMAL; TACHYCARDIA, SUPRAVENTRICULAR;

EID: 84876561034     PISSN: 14767058     EISSN: 14764954     Source Type: Journal    
DOI: 10.3109/14767058.2012.755170     Document Type: Article

References (50)

1. Czeizel AE, Kamarás J, Balogh Ö , Szentpéteri J. Incidence of congenital heart defects in Budapest. Acta Paediat Acad Sci Hung 1982;13:191-202.
2. Hoffman JIE, Kaplan S. The incidence of congenital heart disease. J Am Coll Cardiol 2002;39:1890-900. (Pubitemid 34628268)
3. Calzolary E, Garani G, Cocchi G, et al. Congenital heart defects: 15 years of experience of the Emilia-Romagna Registry (Italy). Eur J Epidemiol 2003;18:773-80. (Pubitemid 37039976)
4. Hoffman JIE, Kaplan S, Liberthson RR. Prevalence of congenital heart disease. Am heart J 2004;147:425-39. (Pubitemid 38880862)
5. Dolk H. Loane M, Garne R. A European Surveillance of Congenital Anomalies (EUROCAT) Working Group. Congenital heart defects in Europe: prevalence and perinatal mortality. 2000 to 2005. Circulation 2011;123:841-9.
6. Mészáros M, Nagy A, Czeizel AE. Incidence of congenital heart disease in Hungary. Hum Hered 1975;25:513-9.
7. Mészáros M, Czeizel AE. Point prevalence at birth of ventricular septal defect in Hungary. Acta Paediat Acad Sci Hung 1978;19:51-4. (Pubitemid 8321906)
8. Penny DJ, Vick III, GW. Ventricular septal defect. Lancet 2011;377:1103-12.
9. Czeizel AE, Rockenbauer M, Siffel CS, Varga E. Description and mission evaluation of the Hungarian Case-Control Surveillance of Congenital Abnormalities, 1980-1996. Teratology 2001;63:176-85. (Pubitemid 32417246)
10. Vereczkey A, Kósa ZS, Csáky-Szunyogh M, et al. Birth outcomes of cases with ventricular septal defects in the function of maternal socio-demographic features-a population-based case-control study. Cent Eur J Med (in press).
11. Czeizel AE The first 25 years of the Hungarian Congenital Abnormality Registry. Teratology 1997;55:299-305. (Pubitemid 27389919)
12. Czeizel AE, Intoody ZS, Modell B. What proportion of congenital abnormalities can be prevented? Brit Med J 1993;306:499-503 (Pubitemid 23053163)
13. Czeizel AE, Petik D, Vargha P. Validation studies of drug exposures in pregnant women. Pharmacoepid Drug Safety 2003;12:409-16. (Pubitemid 36903378)
14. Czeizel AE, Vargha P. Periconceptional folic acid/multivitamin supplementation and twin pregnancy. Am J Obstet Gynecol 2004;191:790-4. (Pubitemid 39298111)
15. Ács N, Bánhidy F, Puho E, Czeizel AE. Maternal influenza during pregnancy and risk of congenital abnormalities in offspring. Birth Defects Res Part A 2005;73:989-95.
16. Ferencz C, Loffredo CA, Rubin JD, Magee CA. Epidemiology of congenital heart diseases. The Baltimore-Washington infant study: 1981-1989. Mount Kisco, NY: Future Publ Co.; 1993.
17. Ferencz C, Loffredo CA, Correa-Villasenor A, Wilson PD. Genetic and environmental risk factors of major cardiovascular malformations: the Baltimore-Washington infant study: 1981-1989. Armonk, NY: Future Publ. Co.; 1997.
18. Mitchell SC, Berendes HW, Clark WMJ. The normal closure of the ventricular septum, Am Heart J 1967;73:334-8.
19. Czeizel AE, Puho HE, Ács N, Bánhidy F. Use of specified critical periods of different congenital abnormalities instead of the first trimester concept. Birth Defects Res Part A 2008;82:139-46. (Pubitemid 351458135)
20. Puho E., Métneki J., Czeizel A.E. Maternal employment status and isolated orofacial clefts in Hungary. Centr Eur J Publ Health 2005;13:144-8. (Pubitemid 41375082)
21. Ács N, Bánhidy F, Puho E, Czeizel AE. Population-based casecontrol study of the common cold during pregnancy and congenital abnormalities. Eur J Epid 2006;21:65-76.
22. Tikkanen J, Heinonen OP. Maternal hyperthermia during pregnancy and cardiovascular malformations in the offspring. Eur J Epid 1991;7:628-35.
23. Botto LD, Lynberg MC, Erickson JD. Congenital heart defect, maternal febrile diseases and multivitamin use: a population-based study. Epidemiology 2001;12:485-90. (Pubitemid 32761985)
24. Oster ME, Riehle-Colarusso T, Alverson C, Correa A. Associations between maternal fever and influenza and congenital heart defects. J Pediatr 2011;158:990-5.
25. Czeizel AE, Ács N, Bánhidy R, et al. Primary prevention of congenital abnormalities due to high fever related maternal diseases by antifever therapy and folic acid supplementation. Curr Women's Health Rev 2007;3:1-11.
26. Holmes LB, Harvey EA, Couli BA et al. The teratogenicity of anticonvulsant drugs. N Eng J Med 2001;344:1132-8. (Pubitemid 32285234)
27. Thomas SV, Ajaykumar B, Sindhu K, et al. Cardiac malformations are increased in infant of mothers with epilepsy. Pediatr Cardiol 2008;29:604-8.
28. Czeizel AE, Bánhidy F. Congenital abnormalities of children born to epileptic women treated with antiepileptic drugs in Hungary-a population-based study. The Open Drug Safety J (TODSJ) 2010;1:40-56.
29. Bánhidy F, Ács N, Puhó HE, Czeizel AE. Paroxysmal supraventricular tachycardia in pregnant women and birth outcomes of their children. Am J Med Genet 2010;150A:380-8.
30. Czeizel AE, Dudás I. Prevention of first occurrence of neural-tube defects by periconceptional vitamin supplementation. N Engl J Med 1992;327:1832-5. (Pubitemid 23003073)
31. Czeizel AE. Reduction of urinary tract and cardiovascular defects by periconceptional multivitamin supplementation. Am J Med Genet 1996;62:179-83.
32. Czeizel AE, Dobó M, Vargha P. Hungarian cohort-controlled trial of periconceptional multivitamin supplementation shows a reduction in certain congenital abnormalities. Birth Defects Res Part A 2004;70:853-61. (Pubitemid 39602196)
33. Czeizel AE. Periconceptional folic acid and multivitamin supplementation for the prevention of neural tube defects and other congenital abnormalities. Birth Defects Res Part A 2009; 85:260-8.
34. Botto LD, Khoury MJ, Mulinare J, Erickson JD. Periconceptional multivitamin use and occurrence of conotruncal heart defects: results from a population-based, case-control study. Pediatrics 1996;9:911-7. (Pubitemid 26398775)
35. Botto LD, Olney RS, Erickson JD. Vitamin supplements and the risk for congenital anomalies other than neural-tube defects. Am J Med Genet 2004;125:12-21. (Pubitemid 38140298)
36. Botto LD, Mulinare J, Erickson JD. Occurrence of congenital heart defects in relation to maternal multivitamin use. Am J Epidemiol 2000;151:878-84. (Pubitemid 30461128)
37. Botto LD, Mulinary J, Erickson JD. Do multivitamin or folic acid supplements reduce the risk for congenital heart defects? Am J Med Genet 2003;121A:95-101 (Pubitemid 37075511)
38. Czeizel AE, Toth M, Rockenbauer M. A case-control analysis of folic acid supplementation during pregnancy. Teratology 1996; 53:345-51. (Pubitemid 26395142)
39. van Beynum IM, Kapusta L, Bakker MK, et al. Protective effect of periconceptional folic acid supplements on the risk of congenital heart defects: a registry-based case-control study in the northern Netherlands. Eur Heart J 2010;31:464-71.
40. Kapusta L, Haagmans ML, Steegers EA, et al. Congenital heart defects and maternal derangement of homocysteine metabolism J Pediatr 1999;135:773-4. (Pubitemid 30180432)
41. Wenstrom KD, Johanning GL, Johnston KE, DuBard M. Association of the C677T methylenetetrahydrofolate reductase mutation an elevated homocysteine levels with congenital cardiac malformations. Am J Obstet Gynecol 2001;184:806-12.
42. Junker R, Kotthoff S, Vielhaber J, et al. Infant methylenetetrahydrofolate reductase 677TT genotype is a risk factor for congenital heart disease. Cardiovasc Res 2001;51:151-4.
43. Hobbs CA, Cleves MA, Karim MA. Maternal folate-related gene environment interactions and congenital heart defects. Obstet Gynecol 2010;116:316-22.
44. Ács N, Bánhidy F, Puhó E, Czeizel AE. Maternal severe migraine and risk of limb deficiencies. Birth Defects Res Part A 2006; 76:592-601. (Pubitemid 44465320)
45. Czeizel AE, Ács N, Bánhidy F. Migraine in pregnant women. Trends Reprod Biol 2008;3:1-8.
46. Källen BAJ, Olausson PO. Maternal drug use in early pregnancy and infant cardiovascular defect. Reprod Toxicol 2003;17:255-61. (Pubitemid 36626946)
47. Nora JJ. From generational studies to a multilevel geneticenvironmental interaction. J Am Coll Cardiol 1994;23:1468-71. (Pubitemid 24158019)
48. Mészáros M, Czeizel AE. ECG conduction disturbance in the firstdegree relatives of children with ventricular septal defect. Hum Hered 1981;19:298-301. (Pubitemid 11067783)
49. Rockenbauer M, Olsen J, Czeizel AE, et al. Recall bias in a casecontrol study on the use of medicine during pregnancy. Epidemiology 2001;12:401-66.
50. Khoury MJ, James LM, Erickson JD. On the use of affected controls to address recall bias in case-control studies of birth defects. Teratology 1994;49:273-81. (Pubitemid 24137961)